Abstract
Background
The WHO’s three-step guideline for cancer pain management has been introduced in China; however, there remain large differences in the standards of cancer pain management between China and other developed countries. This survey was carried out to determine the degree of physician knowledge on morphine use and the factors that impede morphine use in clinical practice in China.
Methods
A self-reported questionnaire was designed and administered to randomly selected physicians in four tertiary hospitals in the cities of Changchun and Changsha in China. Statistical analyses were conducted using SPSS statistical software.
Results
Two hundred and one clinical physicians participated in the survey. Physicians who reported having received training in cancer pain management and drug use demonstrated a significantly higher mean score of basic knowledge compared to physicians who reported not having received training (9.31 ± 2.88:8.23 ± 2.70, u = 2.74, p < 0.001). The top three cited impediments to widespread clinical use of morphine for cancer pain were: (1) lack of professional knowledge and training; (2) fear of opioid addiction; and (3) physicians’ personal preferences to select other drugs.
Conclusions
Medical staffs lack the basic knowledge and harbor misconceptions about the clinical use of morphine for cancer pain treatment. Creating training opportunities for medical staffs is necessary to increase their awareness and knowledge of effective cancer pain management.
Similar content being viewed by others
References
World Health Organization (2003) Global cancer rates could increase by 50% to 15 million by 2020. http://www.who.int/mediacentre/news/releases/2003/pr27/en/
Goldberg GR, Morrison RS (2007) Pain management in hospitalized cancer patients: a systematic review. J Clin Oncol 25:1792–1801
Jeon YS, Kim HK, Cleeland CS, Wang XS (2007) Clinicians’ practice and attitudes toward cancer pain management in Korea. Support Care Cancer 15:463–469
Mercadante S, Lodi F, Sapio M, Calliqara M, Serretta R (1995) Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 10:564–568
Hagen NA, Wasylenko E (1999) Methadone: outpatient titration and monitoring strategies in cancer pain. J Pain Symptom Manage 18:369–375
Hunt R, Fazekas B, Thorne D, Brooksbank M (1999) A comparison of subcutaneous morphine and fentanyl in hospicecancer patients. J Pain Symptom Manage 18:111–119
World Health Organization (1986) Cancer pain relief. World Health Organization, Geneva
World Health Organization (2000) Achieving balance in national opioids control policy. Guidelines for assessment. http://whqlibdoc.who.int/hq/2000/WHO_EDM_QSM_2000.4.pdf
Sun Y, Luo AL et al (2004) The text book of the clinical application and regulation management of narcotic drugs. Ministry of Health Press, Beijing
Sun WZ, Hou WY, Li JH (1996) Republic of China: status of cancer pain and palliative care. J Pain Symptom Manage 12:127–129
Wang WS, Li TD, Yu SY, Gu WP, Xu GW (2002) China: status of pain and palliative care. J Pain Symptom Manage 24:177–179
Liu ZM, Zhou WH, Lian Z et al (1999) A survey of attitudes, knowledge and clinical practice on cancer pain care in Chinese health professionals. Chinese Journal of Pain Medicine 5:1–7
Elliott TE, Murray DM, Elliott BA, Braun B, Oken MM, Johnson KM, Post-White J, Lichtblau L (1995) Physician knowledge and attitudes about cancer pain management: a survey from the Minnesota Cancer Pain Project. J Pain Symptom Manage 10:494–504
Sapir R, Pharm B, Sci MM et al (1999) Cancer pain: knowledge and attitudes of physicians in Israel. J Pain Symptom Manage 17:266–276
Stolerman IP (1991) Drug dependence as pharmacological adaptation. In: Glass IB (ed) The international handbook of addiction behavior. Routledge, London, pp 11–19
World Health Organization (1990) Cancer pain relief and palliative care: Report of a WHO expert committee (Technical report series 804). World Health Organization, Geneva
Chinese Pharmacopoeia Commission (2001) Volume II pharmacopoeia of People’s Republic of China 2000. Chemical Industry Press, Beijing
Dalton JA, Blau W, Carlson J, Mann JD, Bernard S, Toomey T, Pierce S, Germino B (1996) Changing the relationship among nurses' knowledge, self-reported behavior, and documented behavior in pain management: does education make a difference? J Pain Symptom Manage 12:308–319
Brietbart W, Rosenfeld B, Passik SD (1998) The Network Project: a multidisciplinary cancer education and training program in pain management, rehabilitation and psychosocial issues. J Pain Symptom Manage 15:18–26
Howell D, Butler L, Vincent L, Watt-Watson J, Stearns N (2000) Influencing nurses’ knowledge: attitudes and practice in cancer pain management. Cancer Nurs 23:55–63
Wells M, Dryden H, Guild P, Levack P, Farrer K, Mowat P (2001) The knowledge and attitudes of surgical staff towards the use of opioids in cancer pain management: can the hospital palliative care team make a difference? Eur J Cancer Care (Engl) 10:201–211
Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ (2008) Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology. doi:10.1038/sj.npp. 1301479
McCaffery M, Ferrell B (1997) Nurses' knowledge of pain assessment and management: how much progress have we made? J Pain Symptom Manage 14:175–188
Weinstein SM, Laux LF, Thornby JI, Lorimor RJ, Hill CS Jr, Thorpe DM, Merrill JM (2000) Physicians’ attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J 93:479–487
Redmond K (1997) Organizational barriers in opioid use. Support Care Cancer 5:451–456
Zhang H, Gu WP, Joranson DE, Cleeland C (1996) People’s republic of China: status of cancer pain and palliative care. J Pain Symptom Manage 12:124–126
Chang YJ, Yun YH, Park SM, Lee SW, Park H-A, Ro Y-J, Huh BY (2005) Nurses willingness to maximize opioid analgesia for severe cancer pain, and its predictor. Support Care Cancer 13:743–751
Eddy NB, Halbach H, Isbell H, Seevers MH (1965) Drug dependence: its significance and characteristics. Bull Wld Hlth Org 32:721–733
Porter J, Jick H (1980) Addiction rare in patients treated with narcotics. N Engl J Med 302:123
Fan BF (2001) The clinical application of Morphine medicine. Medical Journal of Liaoning 15:174–176
Shiying Y, Wang XS, Yuan C, Jingxiang Y, Cleeland CS (2001) Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain 5:15–20
Sun Y, Gu WP (2002) The principle of the three-step analgesic ladder of cancer, 2nd edn. Peking University Medical Press, Beijing, p 70
Conflict of interest statement
We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service, and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled, “A survey on physician knowledge and attitudes towards clinical use of morphine for cancer pain treatment in China.”
Competing interests
None declared
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors Su Yanjun, Wang Changli, and Zhang Lei contributed equally to this paper.
Implications Statement
Physicians’ knowledge on the use of analgesic drugs in clinical practice, particularly morphine, has advanced considerably in China; however, misconceptions and inadequate knowledge about morphine for cancer pain management remains prevalent among Chinese physicians.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 87 kb)
Rights and permissions
About this article
Cite this article
Yanjun, S., Changli, W., Ling, W. et al. A survey on physician knowledge and attitudes towards clinical use of morphine for cancer pain treatment in China. Support Care Cancer 18, 1455–1460 (2010). https://doi.org/10.1007/s00520-009-0768-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-009-0768-2